Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Pfizer, BioNTech Seeks Emergency Use Nod For COVID-19 Vaccine For Kids 5-11 Years

Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have submitted an FDA Emergency Use Authorization (EUA) application for a 10-µg booster dose of COVID-19 Vaccine for children 5 through 11 years of age. The submission included data from the Phase 2/3 clinical trial in children ages 5 through 11 years who received a booster dose…

Benzinga

Pig producers say pork safe to eat amid Japanese encephalitis virus vaccine rollout success

Pork producers guarantee consumers it is safe to eat pork, as the country continues to manage Japanese encephalitis virus (JEV).

ABC News

Anticipating a side effect makes it more likely you'll experience it – this could contribute to vaccine hesitancy

The COVID pandemic has highlighted several interesting features of modern medical practice – most recently the “nocebo” response, which may account for a significant number of side effects people experience following vaccination.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Immunization requirements are common in US schools but few states have added COVID-19 vaccine mandates

States control vaccine mandates for school students. Some vaccines are required nationwide.

USAFacts

Another delay for five-and-under vaccine

The issue isn't around safety, but instead messaging and vaccine effectiveness

Salon

Pfizer asks FDA to clear COVID booster shot for kids 5-11

Pfizer Inc. asked U.S. regulators for emergency-use authorization of a booster shot of its COVID-19 vaccine in children ages 5 to 11, setting in motion an effort to provide extra protection to kids.

Tribune News Service

COVID-19 vaccination: Nearly 3 lakh citizens yet to take second dose

Health staff tasked with contacting and convincing them to take vaccine

The Hindu

Read news from The Economist, FT, and more,
with one subscription

COVID-19: Survey shows 30% of respondents who had taken third dose vaccine contracted disease during third wave in India

Questionnaire-based survey conducted by a group of Kochi-based doctors among 5,971 adults across the country to assess the community level experience of the pandemic

The Hindu

GeoVax Labs Stock Jumps On US Patent For Malaria Vaccine Candidate

The U.S. Patent and Trademark Office has issued Patent No. 11,311,612 covering GeoVax Labs Inc's (NASDAQ:GOVX) modified vaccinia Ankara (MVA) vector expressing certain antigens from the malaria parasite. GeoVax's MVA-VLP malaria vaccine candidates incorporate antigens derived from multiple stages of the parasite's life cycle. They are designed to induce an immune response with durable…

Benzinga

Valneva - Pfizer Post Encouraging Data From Lyme Disease Vaccine Candidate

Valneva SE (NASDAQ:VALN) and Pfizer Inc (NYSE:PFE) have reported Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15. In pediatric participants (5-17 years old) who received VLA15 in either the two-dose schedule (N=93) or three-dose schedule (N=97), VLA15 was found to be more immunogenic than in adults with both vaccination schedules tested. These…

Benzinga

How Robert Langer, a pioneer in delivering mRNA into the body, failed repeatedly but kept going: 'They said I should give up, but I don't like to give up'

The mRNA vaccines developed against COVID-19 owe a lot to the work of Robert Langer, a pioneer in the delivery of mRNA. Langer, who is the Massachusetts Institute of Technology David H. Koch Institute Professor and director of the Langer Lab, helped lay the foundation for the underlying delivery mechanism…

The Conversation

The Nets’ Season Was Doomed From the Start

Brooklyn had to weather injuries, James Harden’s trade request and other setbacks. But Kyrie Irving’s decision to not get the vaccine stumbled the team out of the gate.

Sports Illustrated

Biotech firm ReViral acquired by Pfizer in £412m deal

ReViral was co-founded by former Durham University lecturer Professor Stuart Cockerill and has a North East research and development facility at Sedgfield's NETPark

Birmingham Post

David Harewood takes on new role as a vaccine champion in Bangladesh

Returning from a trip to the Bangladeshi highlands, the British actor and Unicef goodwill ambassador is calling on the UK government to do more to protect the world’s poorest against future crises

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Corbevax, Covaxin get drug regulator nod for use in children between 5 and 12

Corbevax has been approved for administration in children between ages of 5 and 12 and Covaxin has been approved for restricted use in emergency situations in children aged 6-12

Salon

Poor nations left behind on vaccines

"Do not let history repeat itself," advocates warn as low-income countries lack access to Pfizer treatment

Wales Online

Millions invited to book Covid vaccine: is anyone in your family due a jab?

Parents of children aged five and six are receiving letters offering jabs

Reason

Brickbat: You Will Do What's Good for You

Rhode Island state Sen. Sam Bell has introduced a bill that would require all unvaccinated residents of the state pay a $50-a-month fine. The fine would apply to everyone eligible for the vaccine. Bell's bill would also force unvaccinated Rhode Islanders to pay double their state income taxes.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Consumer Health: First vaccine to prevent malaria

Malaria is caused by a single-celled parasite of the genus Plasmodium. The parasite is transmitted to humans most commonly through mosquito bites. The malaria parasites enter the bloodstream and travel to the liver. When the parasites mature, they leave the liver and infect red blood cells.

Los Angeles Times

Editorial: California’s schools don’t need a vaccine mandate — at least, not right now

Though experts’ understanding of COVID-19 has grown tremendously, the virus that causes it is an ever-changing story, challenging our ability to form policy that works from one season to the next.

ABC News

Liberal candidate for Bennelong Simon Kennedy voiced vaccine mandate concerns at anti-vax meeting

The Liberal Party candidate for the Sydney seat of Bennelong has appeared in a video opposing vaccine mandates and acknowledging there may be concerns about the safety of mRNA vaccines at an event organised by Australia’s anti-lockdown movement.

AAP

WA scraps masks, proof of vaccine mandates

Western Australia is set to abolish quarantine for asymptomatic COVID-19 close contacts and remove proof of vaccination and face mask mandates.

Businessweek

We’re Fighting Covid With Faulty Data

Measurements of illnesses and vaccinations haven’t kept up with the changing nature of the pandemic.

The Independent UK

Pass urgent COVID funding or more will die, White House says

After two years at the front of the line for COVID-19 vaccines and treatments, the U.S. could soon have to begin taking a number

Benzinga

Poland, Moderna Working Towards Increased Flexibility Of COVID-19 Vaccine Contracts: Reuters

Poland can compromise with Moderna Inc (NASDAQ:MRNA) on increasing the flexibility of COVID-19 vaccine contracts, Reuters reported citing the health minister, striking an upbeat tone after initial talks with the company. Poland has said it will not take or pay for more doses of the COVID-19 vaccine under the European Union's supply contract. Reuters…

1 … 303 304 305 306

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.